top of page
Welcome to Linden Oncology Ltd
Linden Oncology Ltd provides haematology/oncology expertise across a wide range of solid and haematological malignancies with a particular focus of late preclinical to phase II development. Linden Oncology works with both big Pharma and oncology biotech companies in Europe, North America and Asia.
SERVICES
Servies
STRATEGIC DEVELOPMENT PLANS
PROTOCOL DEVELOPMENT (PHASE I-IV)
PHARMACOVIGILANCE
INTERACTION WITH REGULATORY AGENCIES ON BEHALF OF CLIENT COMPANIES
PARTICIPATION IN ADVISORY BOARDS/SAFETY REVIEW COMMITTEES
KEY OPINION LEADER DEVELOPMENT
MEDICAL MONITORING SUPPORT
Clients
CLIENTS
Andrew Saunders
Chief Managing Director of Linden Oncology 2007- present
About
Expertise
EXPERTISE
Clinical Development
Oncology
Medical Affairs
Drug Development
Pharmacovigilance
Biopharmaceuticals
CONTACT
bottom of page